Related Experiment Videos
Gonadoblastoma and Y-chromosome fluorescence
Clinical Genetics
|April 1, 1986
Summary
Patients with 45,X/46,XY mosaicism and a fluorescent Y chromosome are at risk for gonadoblastoma. Alterations in Y chromosome fluorescence may protect against this tumor development.
Area of Science:
- Genetics
- Oncology
- Reproductive Medicine
Background:
- Mosaic chromosomal abnormalities, including 45,X/46,XY, are associated with disorders of sex development.
- Gonadoblastoma is a rare tumor that can arise in dysgenetic gonads.
Purpose of the Study:
- To investigate the relationship between Y chromosome fluorescence and gonadoblastoma development in patients with 45,X/46,XY mosaicism.
- To review existing literature on gonadoblastoma in patients with 45,X/46,XY mosaicism and Y chromosome alterations.
Main Methods:
- Case series analysis of patients with 45,X/46,XY and related karyotypes.
- Review of medical literature for documented cases of gonadoblastoma in patients with 45,X/46,XYnf mosaicism.
Main Results:
- Three patients with 45,X/46,XY mosaicism and a fluorescent Y chromosome developed gonadoblastomas.
- Three patients with 45,X/46,XYnf mosaicism (lacking distal Yq fluorescence) did not develop gonadoblastomas.
- Literature review found no documented cases of gonadoblastoma in patients with well-characterized 45,X/46,XYnf mosaicism.
Conclusions:
- Alterations in the distal Yq fluorescence may confer protection against gonadoblastoma in patients with 45,X/46,XY mosaicism.
- Y chromosome fluorescence is a potential indicator for gonadoblastoma risk in individuals with gonadal dysgenesis.